is microdosing tirzepatide safe Microdosing instructions for tirzepatide with

The drug was projected to be launched in 20032 for PD and 2007 for AD, with estimated market shares of 12.5% and 25%, respectively

We recommend 8 weeks on, followed by 4 weeks off before starting another cycle if needed

doi: 10.1111/j.1600-0897.2004.00231.x 42

CV risk profile subgroups To assess the effect of baseline CV risk profiles on outcomes, two separate subgroup analyses were performed: (1) for subjects who had experienced a prior MI or stroke compared with those who had not, and (2) for those with established CVD, defined as prior stroke, ischemic heart disease (including MI), peripheral arterial disease, 50% arterial stenosis in any artery, coronary revascularization (percutaneous coronary intervention or coronary artery bypass graft), or heart failure vs those with CV risk factors alone and no manifestations of CVD as defined above